Annick Landin

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “191 Targeting myeloid-derived suppressor cells (MDSCs) in bladder cancer to enhance efficacy of adoptive cell therapy (ACT)”.

191 Targeting myeloid-derived suppressor cells (MDSCs) in bladder cancer to enhance efficacy of adoptive cell therapy (ACT)

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0191

N/A

0DataRank · unranked

0 citations

Brittany Bunch, Jamie Blauvelt, Annick Landin, Johannes Ali, Dominique Abrahams +5 more

Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer

Frontiers in Immunology(2023)10.3389/fimmu.2023.1275375

N/A

0DataRank · unranked

23 citations

Brittany Bunch, Awino Maureiq E. Ojwang’, Jamie Blauvelt, Annick Landin, Johannes Ali +8 more